Drug intelligence / Profile preview

IL-4 + IFN-γ

Development stage
Preclinical
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
01

Overview

IL-4 + IFN-γ is a combination of two recombinant cytokines—interleukin 4 (IL-4) and interferon gamma (IFN-γ)—used primarily in research settings to study immune modulation. Both are key immunoregulatory proteins with distinct but sometimes overlapping roles in the immune system. IL-4 is mainly associated with promoting humoral immunity, B cell differentiation, and anti-inflammatory responses, while IFN-γ is central to cell-mediated immunity and antiviral defense. When used together, these cytokines can have complex effects on immune cells such as dendritic cells and B cells; they may act synergistically or antagonistically depending on context. For example, their combination can induce unique gene expression profiles in dendritic cells[1], modulate B cell proliferation and antibody class switching[5], or influence T-cell activation. This combination has been explored experimentally for its potential to modulate immune responses in diseases like cancer[4] or viral infections but does not have an established clinical use as a marketed pharmaceutical product.

Other names
Interleukin 4 + Interferon gammaIL-4 and IFN-gammaIL4 and IFN-gammaIL 4 and IFN-gammaInterleukin 4 and Interferon gammaInterleukin4 and Interferon gammaInterleukin-4 and Interferon gamma
02

Targets

IFNGR1 (Interferon gamma receptor 1)IL4R (Interleukin-4 receptor alpha subunit)

Beyond the preview

Go deeper on IL-4 + IFN-γ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IL-4 + IFN-γ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call